Literature DB >> 35972665

ASO Visual Abstract: Neoadjuvant Chemotherapy and Endoprosthetic Reconstruction for Lower-Extremity Sarcomas-Does Timing Impact Complication Rates?

Aaron M Gazendam1, Patricia Schneider2, Andre Spiguel3, Michelle Ghert2.   

Abstract

Entities:  

Mesh:

Year:  2022        PMID: 35972665     DOI: 10.1245/s10434-022-12374-7

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   4.339


× No keyword cloud information.
  1 in total

1.  ASO Author Reflections: Timing of Neoadjuvant Chemotherapy in Patients with Sarcoma.

Authors:  Aaron M Gazendam; Michelle Ghert
Journal:  Ann Surg Oncol       Date:  2022-07-26       Impact factor: 4.339

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.